05/30/2024
7:05 AM | Akili, Inc. (Subject)
Akili, Inc. (Subject)
PureTech Health (Filed by)
PureTech Health plc (Filed by)
| Form SC 13D/A | |
05/29/2024
3:33 PM | PureTech Health (Filer)
PureTech Health plc (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/20/2024
3:30 PM | PureTech Health (Filer)
PureTech Health plc (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/20/2024
6:03 AM | PureTech Health (Subject)
PureTech Health plc (Subject)
| Form SC TO-I | |
04/25/2024
10:57 AM | PureTech Health (Filer)
PureTech Health plc (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
04/25/2024
5:30 AM | PureTech Health (Filer)
PureTech Health plc (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/09/2024
5:30 AM | PureTech Health (Filer)
PureTech Health plc (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/19/2024
7:30 AM | PureTech Health (Filer)
PureTech Health plc (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/19/2024
7:32 AM | PureTech Health (Subject)
PureTech Health plc (Subject)
| Form SC TO-C | |
03/18/2024
3:30 PM | PureTech Health (Filer)
PureTech Health plc (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/04/2024
3:51 PM | PureTech Health (Filer)
PureTech Health plc (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2023
5:30 AM | PureTech Health (Filer)
PureTech Health plc (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/05/2023
3:30 PM | PureTech Health (Filer)
PureTech Health plc (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/02/2023
3:30 PM | PureTech Health (Filer)
PureTech Health plc (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/21/2023
3:30 PM | GELESIS HOLDINGS, INC. (Issuer)
GELESIS HOLDINGS, INC. (Issuer)
PureTech Health LLC (Reporting)
PureTech Health (Reporting)
PureTech Health plc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
3:30 PM | PureTech Health (Filer)
PureTech Health plc (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/29/2023
5:33 AM | PureTech Health (Filer)
PureTech Health plc (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/06/2023
3:30 PM | PureTech Health (Filer)
PureTech Health plc (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/14/2023
3:30 PM | GELESIS HOLDINGS, INC. (Issuer)
GELESIS HOLDINGS, INC. (Issuer)
PureTech Health LLC (Reporting)
PureTech Health (Reporting)
PureTech Health plc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
3:32 PM | PureTech Health (Filer)
PureTech Health plc (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/02/2023
3:31 PM | PureTech Health (Filer)
PureTech Health plc (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/31/2023
4:30 PM | GELESIS HOLDINGS, INC. (Issuer)
GELESIS HOLDINGS, INC. (Issuer)
PureTech Health LLC (Reporting)
PureTech Health (Reporting)
PureTech Health plc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
